Clinical value of flow cytometric immunophenotypic analysis for minimal residual disease detection in autologous stem-cell products of follicular and mantle cell lymphomas

被引:0
|
作者
H Kato
K Yamamoto
Y Oki
S Ine
H Taji
D Chihara
Y Kagami
M Seto
Y Morishima
机构
[1] Aichi Cancer Center Hospital,Department of Hematology and Cell Therapy
[2] Aichi Cancer Center Research Institute,Division of Molecular Medicine
来源
Leukemia | 2012年 / 26卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:166 / 169
页数:3
相关论文
共 50 条
  • [21] Minimal residual disease after allogeneic and autologous stem cell transplant in myeloma
    Owen, RG
    Bybee, A
    Cooke, F
    Haynes, AP
    Johnson, RG
    Smith, GM
    Child, JA
    Russell, NH
    Morgan, G
    Samson, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 620 - 620
  • [22] Next-Generation Sequencing Minimal Residual Disease of Mantle Cell Lymphoma in Autologous Stem Cell Grafts and Its Implication on Tumor Recurrence
    Wang, Yu-Hung
    Chuang, Yi-Kuang
    Yang, Yu-Hsuan
    Yu, Shan-Chi
    Yang, Yi-Tsung
    Ko, Bor-Sheng
    Yao, Ming
    Huang, Tai-Chung
    Tang, Jih-Luh
    BLOOD, 2020, 136
  • [23] Aggressive and extramedullary plasma cell myeloma evade bone marrow flow cytometric minimal residual disease detection
    Came, Neil
    Vuong Nguyen
    Westerman, David
    Harrison, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (06) : 947 - 949
  • [24] Comparative analysis of immunophenotypic methods for the assessment of minimal residual disease in hairy cell leukemia
    Bengiò, R
    Narbaitz, MI
    Sarmiento, MA
    Palacios, MF
    Scolnik, MP
    HAEMATOLOGICA, 2000, 85 (11) : 1227 - 1229
  • [25] MOLECULAR DETERMINATION OF MINIMAL RESIDUAL DISEASE IN PERIPHERAL-BLOOD STEM-CELL HARVESTS
    LANGLANDS, K
    CRAIG, JIO
    PARKER, AC
    ANTHONY, RS
    BONE MARROW TRANSPLANTATION, 1990, 5 : 64 - 65
  • [26] Immunophenotypic Analysis of Peripheral T-Cell Lymphomas: A Single-Center Retrospective Review of Flow Cytometric Analysis
    Abbott, Daniel
    Kroft, Steven
    Hintzke, Maria
    Carrillo-Polanco, Luis
    Cunningham, Ashley
    Astle, John
    Leventaki, Vasiliki
    Harrington, Alexandra
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 : S109 - S109
  • [27] The clinical value of tumor-informed minimal residual disease detection in renal cell carcinoma
    Wang, L.
    Gan, X.
    Huang, F.
    Ding, J.
    Hao, Q.
    Wang, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1024 - S1024
  • [28] Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation (vol 28, pg 2503, 2017)
    Takamatsu, H.
    Takezako, N.
    Zheng, J.
    Moorhead, M.
    Carlton, V. E. H.
    Kong, K. A.
    Murata, R.
    Ito, S.
    Miyamoto, T.
    Yokoyama, K.
    Matsue, K.
    Sato, T.
    Kurokawa, T.
    Yagi, H.
    Terasaki, Y.
    Ohata, K.
    Matsumoto, M.
    Yoshida, T.
    Faham, M.
    Nakao, S.
    ANNALS OF ONCOLOGY, 2023, 34 (03) : 322 - 322
  • [29] FLOW CYTOMETRIC QUANTITATION OF CD34+ STEM-CELLS IN PERIPHERAL STEM-CELL APHERESIS PRODUCTS
    PIRRUCCELLO, SJ
    COLLINS, MM
    JACKSON, JD
    LETHEBY, BA
    KESSINGER, A
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 758 - 758
  • [30] Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL
    P Lúcio
    A Parreira
    MWM van den Beemd
    EG van Lochem
    ER van Wering
    E Baars
    A Porwit-MacDonald
    E Bjorklund
    G Gaipa
    A Biondi
    A Orfao
    G Janossy
    JJM van Dongen
    JF San Miguel
    Leukemia, 1999, 13 : 419 - 427